| pubmed-article:12680167 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12680167 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:12680167 | lifeskim:mentions | umls-concept:C0029925 | lld:lifeskim |
| pubmed-article:12680167 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:12680167 | lifeskim:mentions | umls-concept:C0005290 | lld:lifeskim |
| pubmed-article:12680167 | lifeskim:mentions | umls-concept:C0522498 | lld:lifeskim |
| pubmed-article:12680167 | pubmed:issue | 1B | lld:pubmed |
| pubmed-article:12680167 | pubmed:dateCreated | 2003-4-8 | lld:pubmed |
| pubmed-article:12680167 | pubmed:abstractText | The interaction between paclitaxel and its target, beta tubulin, is essential for effective cytotoxicity. Alterations or mutation of beta tubulin have the potential to alter paclitaxel binding and confer a drug resistant phenotype. | lld:pubmed |
| pubmed-article:12680167 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12680167 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680167 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12680167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680167 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12680167 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:12680167 | pubmed:author | pubmed-author:OlivaEstherE | lld:pubmed |
| pubmed-article:12680167 | pubmed:author | pubmed-author:SeidenMichael... | lld:pubmed |
| pubmed-article:12680167 | pubmed:author | pubmed-author:PensonRichard... | lld:pubmed |
| pubmed-article:12680167 | pubmed:author | pubmed-author:LamendolaDian... | lld:pubmed |
| pubmed-article:12680167 | pubmed:author | pubmed-author:DuanZhenfengZ | lld:pubmed |
| pubmed-article:12680167 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12680167 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:12680167 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12680167 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12680167 | pubmed:pagination | 681-6 | lld:pubmed |
| pubmed-article:12680167 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:meshHeading | pubmed-meshheading:12680167... | lld:pubmed |
| pubmed-article:12680167 | pubmed:articleTitle | beta tubulin mutations are rare in human ovarian carcinoma. | lld:pubmed |
| pubmed-article:12680167 | pubmed:affiliation | Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, USA. | lld:pubmed |
| pubmed-article:12680167 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12680167 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12680167 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12680167 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12680167 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12680167 | lld:pubmed |
